John Wiley & Sons, Inc., announced today thatJournal
of Cellular and Molecular Medicine and Microbial
Biotechnology have joined theWiley
Open Access publishing program. All articles in these two journals
are now open access and free to view, download and share.
Since its launch in 1996, Journal
of Cellular and Molecular Medicine has attracted very high
quality submissions and attained an Impact Factor of 4.125, placing it
22nd in the Medicine Research and Experimental ISI Category. With its
emphasis on translational medicine, and high quality review series, Journal
of Cellular and Molecular Medicine is of interest to a wide spectrum
of researchers and clinicians. Converting to open access allows all
readers to benefit from the high-level research advances reported in the
journal, driving biomedical research forward and accelerating discovery.
”We are excited that Journal of Cellular and Molecular Medicine is
joining the Wiley Open Access publishing program, as it will make the
highly topical and well-regarded review series commissioned by our
Editor-in-Chief, Professor LM Popescu, available to all,” said Dr. Jo
Wixon, Senior Editor, Health Sciences, Wiley.
Since its inception, Microbial
Biotechnology has published papers of original research
reporting significant advances in any aspect of microbial applications
to biotechnologies, making it of interest to a wide spectrum of
researchers across the scope of both Microbiology and Biotechnology.
Converting to open access will significantly benefit readers and
researchers in the field of biotechnology, through the dissemination of
high quality research from Microbial Biotechnology.
“The Society for Applied Microbiology is delighted that this change is
taking place. Enabling readers to access the contents of this already
successful journal free of charge will foster progress in this important
area of applied microbiology,” said Society for Applied Microbiology
(SfAM) President, Professor Martin Adams.
“Last year Wiley successfully converted EMBO
Molecular Medicine and Evolutionary
Applications to open access from a subscription model. With this
experience we are confident that these well-established journals will
continue to thrive as they join our program of fully open access
journals,” said Rachel Burley, Vice President and Director, Open Access,
Wiley. “The Wiley Open Access program’s promise of quality is being
realized as we now have four journals with Impact Factors; Ecology
and Evolution is set to get its first Impact Factor this summer;
and MicrobiologyOpen and Journal
of the American Heart Association have both recently been
accepted for Indexing in MEDLINE.”
Journal
of Cellular and Molecular Medicine and Microbial
Biotechnology will publish all from January 2013 under the
Creative Commons Attribution (CC-BY) License, which permits use,
distribution, reproduction and adaptation in any medium, provided the
original work is properly cited. A publication fee will be payable by
authors or their funder on acceptance of their primary research
articles. Authors affiliated with, or funded by, an organization that
has a Wiley
Open Access Account can publish without directly paying any
publication charges.
Please visit the Journal
of Cellular and Molecular Medicine and Microbial
Biotechnology websites for further information and future
updates.
About Wiley Open Access:
Wiley Open Access is an initiative from Wiley to drive quality peer
reviewed publishing with speed and efficiency through open access
publication. All research articles published in Wiley Open Access
journals are immediately freely available to read, download and share.
The fully open access journals are published in collaboration with
authoritative journals and societies as well as supported by
internationally renowned editorial board members. For more information,
please visit http://www.wileyopenaccess.com.
About Wiley:
Founded in 1807, John Wiley & Sons, Inc. has been a valued source of
information and understanding for more than 200 years, helping people
around the world meet their needs and fulfill their aspirations. Wiley
and its acquired companies have published the works of more than 450
Nobel laureates in all categories: Literature, Economics, Physiology or
Medicine, Physics, Chemistry, and Peace.
Wiley is a global provider of content and content-enabled workflow
solutions in areas of scientific, technical, medical, and scholarly
research; professional development; and education. Our core businesses
produce scientific, technical, medical, and scholarly journals,
reference works, books, database services, and advertising; professional
books, subscription products, certification and training services and
online applications; and education content and services including
integrated online teaching and learning resources for undergraduate and
graduate students and lifelong learners. Wiley's global headquarters are
located in Hoboken, New Jersey, with operations in the U.S., Europe,
Asia, Canada, and Australia. The Company's Web site can be accessed at http://www.wiley.com.
The Company is listed on the New York Stock Exchange under the symbols
JWa and JWb.
